Uh oh Trelegy trial SLAMMED!

The company isn’t horrible, just ran horrible in some areas that’s been well documented and changed over several times.

 

FINES! I smell a FINE COMING!

CIA part 2!

 

Haters will hate.

 

Launch a blockbuster with faulty data????? I’m gonna need more Olive Garden! Speaker Programs with almost retired doctors because no one else will ruin their reputation on this. Might need Ventolin to get into offices again.

Over/under 6 months till the first late night lawyer commercial?

 

You don’t get approved for publication in The New England Journal of Medicine with “flawed data” or a bogus trial. That would destroy the credibility of this prestigious journal. The Editorial is exactly that, an Editorial. It’s meant to build/enhance scientific discussion. Relax.

 

Word on the street is...Anoro Reps will begin training for Oncology division next year.

 

Call BS in this!

 

Note to everyone.........please do not call Bob Stratford, he was fired last March.

 

“GSK’s trial design “probably resulted in falsely exaggerating the benefit of triple therapy.” ..............Sounds like they enhancing the discussion like we enhanced our data.

 

Well all this launch buildup and it’s not like a solid trial.